C22 aldehyde

structure in first source

Also Known As:

all-trans-C22 aldehyde

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Horrigan, Diana M: 1 article (12/2006)
2.	Kim, Jennifer A: 1 article (12/2006)
3.	Tetreault, Michelle L: 1 article (12/2006)
4.	Zimmerman, Anita L: 1 article (12/2006)

1.	Retinal Diseases 12/29/2006 - "Our results raise the possibility that retinoids, such as all-trans C22 aldehyde, that inhibit CNG channels without affecting the transduction cascade, may be useful in treating degenerative retinal diseases in which either the cGMP concentration is elevated or the CNG channels are hypersensitive to cGMP."

1.	Retinoids